跳至主要内容
临床试验/ACTRN12614000166673
ACTRN12614000166673招募中未知

A randomised controlled feasibility trial to determine the efficacy of diabetes specific formulae to reduce exogenous insulin doses required to obtain acceptable glycaemic control when compared to the standard nutritional formula in critically ill tube fed patients

Mater Foundation and Mater Research Institute0 个研究点目标入组 54 人开始时间: 2014年2月11日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
54

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • A patient is receiving exclusive enteral nutrition and requires an insulin infusion. Patients with two consecutive blood glucose levels > 10mmol/L are likely to commence on an insulin infusion based on the units’ glucose management protocol.

排除标准

  • The exclusion criteria for this study include patients <18, declined consent by patient/ legally authorised representative, or if recruitment to the study is deemed clinically inappropriate by the treating physician.

研究者

发起方
Mater Foundation and Mater Research Institute

相似试验